Barclays’s Chimera Investment CIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.14M Sell
90,446
-102,822
-53% -$1.34M ﹤0.01% 2680
2025
Q4
$2.4M Buy
193,268
+34,132
+21% +$434K ﹤0.01% 2802
2025
Q3
$2.1M Sell
159,136
-26,165
-14% -$364K ﹤0.01% 2853
2025
Q2
$2.57M Buy
185,301
+54,480
+42% +$696K ﹤0.01% 2661
2025
Q1
$1.68M Sell
130,821
-75,238
-37% -$1.06M ﹤0.01% 2759
2024
Q4
$2.88M Buy
206,059
+22,764
+12% +$341K ﹤0.01% 2614
2024
Q3
$2.9M Buy
183,295
+137,655
+302% +$2.06M ﹤0.01% 2543
2024
Q2
$584K Sell
45,640
-22,978
-33% -$291K ﹤0.01% 2951
2024
Q1
$949K Sell
68,618
-56,236
-45% -$783K ﹤0.01% 3160
2023
Q4
$1.87M Buy
124,854
+84,743
+211% +$1.28M ﹤0.01% 2970
2023
Q3
$657K Buy
40,111
+10,131
+34% +$178K ﹤0.01% 2628
2023
Q2
$519K Sell
29,980
-9,367
-24% -$149K ﹤0.01% 2736
2023
Q1
$666K Sell
39,347
-393,083
-91% -$7.52M ﹤0.01% 3055
2022
Q4
$7.14M Buy
432,430
+379,868
+723% +$7.08M ﹤0.01% 1393
2022
Q3
$823K Buy
52,562
+496
+1% +$12.9K ﹤0.01% 2365
2022
Q2
$1.38M Sell
52,066
-23,322
-31% -$692K ﹤0.01% 2118
2022
Q1
$2.72M Sell
75,388
-96,245
-56% -$3.83M ﹤0.01% 1635
2021
Q4
$7.76M Buy
171,633
+56,456
+49% +$2.67M ﹤0.01% 1420
2021
Q3
$5.13M Buy
115,177
+34,653
+43% +$1.55M ﹤0.01% 1628
2021
Q2
$3.64M Sell
80,524
-28,099
-26% -$1.17M ﹤0.01% 1786
2021
Q1
$4.14M Buy
108,623
+39,334
+57% +$1.34M ﹤0.01% 1682
2020
Q4
$2.13M Sell
69,289
-8,108
-10% -$235K ﹤0.01% 2186
2020
Q3
$1.9M Sell
77,397
-7,982
-9% -$213K ﹤0.01% 2148
2020
Q2
$2.46M Sell
85,379
-247,127
-74% -$6.35M ﹤0.01% 1919
2020
Q1
$9.08M Buy
332,506
+194,289
+141% +$11M 0.01% 1043
2019
Q4
$8.53M Sell
138,217
-22,537
-14% -$1.37M ﹤0.01% 1525
2019
Q3
$9.43M Sell
160,754
-109,687
-41% -$6.38M 0.01% 1326
2019
Q2
$15.3M Buy
270,441
+93,559
+53% +$5.3M 0.01% 1089
2019
Q1
$9.94M Sell
176,882
-19,390
-10% -$1.09M 0.01% 1224
2018
Q4
$10.5M Sell
196,272
-156,490
-44% -$8.56M 0.01% 1128
2018
Q3
$19.2M Buy
352,762
+211,003
+149% +$11.9M 0.01% 879
2018
Q2
$7.78M Buy
141,759
+29,958
+27% +$1.62M 0.01% 1404
2018
Q1
$5.84M Buy
111,801
+45,377
+68% +$2.38M ﹤0.01% 1531
2017
Q4
$3.68M Buy
66,424
+1,198
+2% +$67.1K ﹤0.01% 1894
2017
Q3
$3.7M Buy
65,226
+6,387
+11% +$362K ﹤0.01% 1772
2017
Q2
$3.29M Sell
58,839
-1,643
-3% -$95K ﹤0.01% 1803
2017
Q1
$3.66M Sell
60,482
-4,470
-7% -$249K ﹤0.01% 1560
2016
Q4
$3.32M Sell
64,952
-2,085
-3% -$102K ﹤0.01% 1697
2016
Q3
$3.21M Sell
67,037
-41,010
-38% -$2.01M ﹤0.01% 1619
2016
Q2
$5.09M Sell
108,047
-251,160
-70% -$11.1M 0.01% 1298
2016
Q1
$14M Buy
359,207
+8,032
+2% +$312K 0.02% 617
2015
Q4
$13.7M Buy
351,175
+314,015
+845% +$13.2M 0.02% 743
2015
Q3
$1.45M Sell
37,160
-195,107
-84% -$8.22M ﹤0.01% 2397
2015
Q2
$9.06M Sell
232,267
-12,044
-5% -$538K 0.01% 1096
2015
Q1
$11M Sell
244,311
-14,325
-6% -$685K 0.01% 1019
2014
Q4
$11.6M Sell
258,636
-1,510
-0.6% -$73K 0.01% 1083
2014
Q3
$11.7M Buy
260,146
+104
+0% +$5.01K 0.01% 1062
2014
Q2
$11.7M Sell
260,042
-646
-0.2% -$30.4K 0.01% 1032
2014
Q1
$11.7M Buy
260,688
+74,685
+40% +$3.48M 0.01% 1034
2013
Q4
$8.37M Buy
186,003
+181,263
+3,824% +$8.25M 0.01% 1392
2013
Q3
$213K Sell
4,740
-5,495
-54% -$244K ﹤0.01% 4977
2013
Q2
$461K Buy
+10,235
New +$486K ﹤0.01% 4302

Other funds holding CIM

Barclays's CIM Position: Q1 2026 in Review

Barclays reduced its Chimera Investment (CIM) stake by 53% in Q1 2026, selling an estimated $1.34M and leaving 90,446 shares worth $1.14M. The position accounts for ﹤0.01% of the portfolio, ranked #2680.

Barclays first reported a position in CIM in Q2 2013 and has held it in 52 quarters since. The position peaked at $19.2M in Q3 2018. 198 funds tracked by Wall St. Rank hold CIM as of Q1 2026.

  • Barclays held 90,446 shares of Chimera Investment worth $1.14M as of Q1 2026.
  • Barclays sold 102,822 Chimera Investment shares in Q1 2026, an estimated $1.34M.
  • Chimera Investment made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #2680 holding.
  • Barclays first reported a position in Chimera Investment in Q2 2013 and has held it in 52 quarters since.
  • Barclays's Chimera Investment position peaked at $19.2M in Q3 2018.
  • 198 funds tracked by Wall St. Rank held Chimera Investment as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.